otcbargains undervalued stock board

[JB3729]

AVXL has a legitimate chance to own the Alzheimer's disease market, IMO. The first data from their Phase 2 trial was so much better than anything anyone else has ever reported.

The data was only for the first 12 patients and for only 36 days. Still, it's shown that 2-73 is working 4X better than donepezil, the current standard of care over that time period. AVXL should be given a hard look.

Some info -

http://www.heraldsun.com.au/news/victorians-first-to-trial-breakthrough-brain-booster-pill/story-fni0fiyv-1227453139615
A PILL to treat Alzheimer’s disease is four times more effective than the current treatment in boosting the brain power of patients.
“We’ve also had patients and their carers reporting improvements in their thinking, increased alertness and improvement in their organisation and independence,” Prof Macfarlane said.

https://au.news.yahoo.com/video/watch/29015798/new-pills-offer-hope-for-alzheimers-sufferers/#page1
"It's like being in the dark and someone switched the light on."

http://www.endevr.com/dementia/New-drug-might-help-prevent-slow-or-reverse-Alzheimer-s
Findings in a recent peer-reviewed scientific journal reveals that our lead drug, ANAVEX 2-73 has the potential to prevent, stop, slow or reverse the disease, in addition to treating its symptoms.